Improved survival of patients with multiple myeloma after the introduction of novel agents and the applicability of the International Staging System (ISS): an analysis of the Greek Myeloma Study Group (GMSG). [electronic resource]
Producer: 20090707Description: 1152-7 p. digitalISSN:- 1476-5551
- Age Factors
- Aged
- Analysis of Variance
- Boronic Acids -- therapeutic use
- Bortezomib
- Drug Evaluation
- Female
- Greece
- Humans
- Lenalidomide
- Male
- Multiple Myeloma -- diagnosis
- Neoplasm Staging -- statistics & numerical data
- Pyrazines -- therapeutic use
- Retrospective Studies
- Survival Rate
- Thalidomide -- analogs & derivatives
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.